nitrates has been researched along with Malignant Melanoma in 13 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our purpose was to determine the maximum tolerated dose and toxicity associated with soluble Chinese hamster ovary [s(CHO)] recombinant human interleukin (IL) 1 receptor (IL-1R; Immunex, Seattle, WA) administration in humans and to determine the effective biological dose and/or maximum tolerated dose of the s(CHO) IL-1R in combination with high-dose IL-2 as determined by reduction in IL-2 toxicity and modulation of its biological effects." | 2.69 | A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor. ( Atkins, MB; Clancy, M; Kappler, K; Klempner, M; McDermott, DF; Mier, JW; Rand, W; Ronayne, L; Sorce, D; Trehu, EG, 1998) |
| "Pseudomelanoma is a pathological entity describing the histological findings in cases of recurrences of a partially excised melanocytic nevus, resembling melanoma." | 1.33 | Pseudomelanoma after Solcoderm treatment. ( Amichai, B; Gat, A; Grunwald, MH, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fekkes, D | 1 |
| Van Gool, AR | 1 |
| Bannink, M | 1 |
| Sleijfer, S | 1 |
| Kruit, WH | 1 |
| van der Holt, B | 1 |
| Eggermont, AM | 1 |
| Hengeveld, MW | 1 |
| Stoter, G | 1 |
| Grunwald, MH | 1 |
| Gat, A | 1 |
| Amichai, B | 1 |
| Ferrer, P | 1 |
| Asensi, M | 1 |
| Priego, S | 1 |
| Benlloch, M | 1 |
| Mena, S | 1 |
| Ortega, A | 1 |
| Obrador, E | 1 |
| Esteve, JM | 1 |
| Estrela, JM | 1 |
| Ma, SF | 1 |
| Nishikawa, M | 1 |
| Hyoudou, K | 1 |
| Takahashi, R | 1 |
| Ikemura, M | 1 |
| Kobayashi, Y | 1 |
| Yamashita, F | 1 |
| Hashida, M | 1 |
| Brenner, S | 2 |
| Wolf, R | 1 |
| Michowitz, M | 1 |
| Dascalu, DI | 1 |
| Shafir, R | 1 |
| Azizi, E | 1 |
| Ogilvie, AC | 1 |
| Hack, CE | 1 |
| Wagstaff, J | 1 |
| van Mierlo, GJ | 1 |
| Erenberg, AJ | 1 |
| Thomsen, LL | 1 |
| Hoekman, K | 1 |
| Rankin, EM | 1 |
| Citterio, G | 1 |
| Pellegatta, F | 1 |
| Lucca, GD | 1 |
| Fragasso, G | 1 |
| Scaglietti, U | 1 |
| Pini, D | 1 |
| Fortis, C | 1 |
| Tresoldi, M | 1 |
| Rugarli, C | 1 |
| McDermott, DF | 1 |
| Trehu, EG | 1 |
| Mier, JW | 1 |
| Sorce, D | 1 |
| Rand, W | 1 |
| Ronayne, L | 1 |
| Kappler, K | 1 |
| Clancy, M | 1 |
| Klempner, M | 1 |
| Atkins, MB | 1 |
| Fecker, LF | 1 |
| Eberle, J | 1 |
| Orfanos, CE | 1 |
| Geilen, CC | 1 |
| Goldenhersh, MA | 1 |
| Scheflan, M | 1 |
| Zeligovsky, A | 1 |
| Lahmer, H | 1 |
| Jung, HD | 1 |
3 trials available for nitrates and Malignant Melanoma
| Article | Year |
|---|---|
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.
Topics: Adult; Antineoplastic Agents; Cell Degranulation; Complement Activation; Female; Humans; Interleukin | 1996 |
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2.
Topics: Adult; Aged; Carcinoma, Renal Cell; Cardiovascular Diseases; Drug Administration Schedule; Female; H | 1996 |
A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Autoimmunity; C-Reactive Protein; Carcinoma, Renal Cell | 1998 |
10 other studies available for nitrates and Malignant Melanoma
| Article | Year |
|---|---|
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy.
Topics: Adult; Aged; Arginine; Blood Platelets; Carcinoma, Renal Cell; Citrulline; Female; Humans; Interfero | 2009 |
Pseudomelanoma after Solcoderm treatment.
Topics: Acetic Acid; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Copper; Derm | 2006 |
Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma.
Topics: Animals; Cell Adhesion; Cell Death; Cell Line, Tumor; Down-Regulation; Endothelium, Vascular; Flavon | 2007 |
Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Catalas | 2007 |
Risk of melanoma after treatment of pigmented lesions with Solcoderm.
Topics: Acetates; Acetic Acid; Adult; Antineoplastic Combined Chemotherapy Protocols; Copper; Dermatologic A | 1993 |
Is Solcoderm a treatment for pigmented lesions?
Topics: Acetates; Acetic Acid; Aged; Antineoplastic Combined Chemotherapy Protocols; Copper; Female; Humans; | 1993 |
Approach to the treatment of pigmented skin lesions.
Topics: Acetates; Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Copper; Diagnostic Errors; Hu | 1993 |
Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Enzyme Inhibitors; Gene Expression Regulation, E | 2002 |
Recurrent melanocytic nevi after Solcoderm therapy: a new cause of pseudomelanoma.
Topics: Acetates; Acetic Acid; Adult; Antineoplastic Combined Chemotherapy Protocols; Copper; Diagnosis, Dif | 1992 |
[Experiences of the demonstration of indole melanogens in urine in malignant melanomas].
Topics: Acetates; Catechol Oxidase; Chlorides; Clinical Enzyme Tests; Diagnosis, Differential; Ferricyanides | 1971 |